Evidence map›Paper›PMID 29997146›Full record

ArticleJournal of investigative medicine : the official publication of the American Federation for Clinical Research2018

Weidong Zhang, Gul Ahmad, Adebayo J Molehin, Workineh Torben, Loc Le, Eunjee Kim, Samra Lazarus, Arif J Siddiqui, Darrick Carter, Afzal A Siddiqui

Open access · greenAbstract read
In one paragraph

Article in Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 26 citations in OpenAlex.

  1. Oxidative medicine and cellular longevity · 2019
    Trial
  2. Article
  3. Article
  4. Review
  5. Roles of cytokines in modulatingFrontiers in parasitology · 2025
    Article
  6. Transmission-Blocking Vaccines against Schistosomiasis Japonica.International journal of molecular sciences · 2024
    Review
  7. Review
  8. Human Schistosomiasis Vaccines as Next Generation Control Tools.Tropical medicine and infectious disease · 2023
    Article
  9. Anti-schistosomal immunity to core xylose/fucose in N-glycans.Frontiers in molecular biosciences · 2023
    Article
  10. Review
  11. Review
  12. De Novo Design of Cathepsin B1 Inhibitors as Potential Anti-Schistosomal Agents Using Computational Studies.Advances and applications in bioinformatics and chemistry : AABC · 2022
    Article
  13. A comprehensive and critical overview of schistosomiasis vaccine candidates.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021
    Review
  14. Review
  15. Immune responses in liver and spleen againstJournal of advanced research · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.Frontiers in cellular and infection microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Weidong Zhang *Center for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Gul Ahmad *Department of Natural Sciences, School of Arts & Sciences, Peru State College, Peru, Nebraska, USA.
Adebayo J MolehinCenter for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Workineh TorbenComparative Pathology/Immunology, Tulane National Primate Research Center, Covington, Louisiana, USA.
Loc LeBladder Immunology Group, Biomedical Research Institute, Rockville, Maryland, USA.
Eunjee KimCenter for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Samra LazarusCenter for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Arif J SiddiquiCenter for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Darrick CarterPAI Life Sciences, Seattle, Washington, USA.
Afzal A SiddiquiCenter for Tropical Medicine and Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Texas Tech University · USTexas Tech University Health Sciences Center · USBiomedical Research Institute · USPAI Life Sciences (United States) · USPeru State College · USTulane University · US

Funding

A Vaccine for Schistosomiasis, "SchistoShield"R44AI103983 · NIAID · PAI LIFE SCIENCES, INC. · PI CARTER, DARRICK ALBERT, SIDDIQUI, AFZAL A · 2016 to 2022
$5.5M
Process Development on a Schistosomiasis Vaccine, SchistoShield???R43AI103983 · NIAID · PAI LIFE SCIENCES, INC. · PI CARTER, DARRICK ALBERT, SIDDIQUI, AFZAL A · 2013 to 2014
$600k
NIAID NIH HHS HHSN272201000005INIAID NIH HHS R43 AI103983NIAID NIH HHS R44 AI103983
6 · The paper itself

Abstract

Sm-p80, the large subunit of

Indexed as

Adjuvants, ImmunologicAlum CompoundsAnimalsAntigens, HelminthCell ProliferationCytokinesFemaleGlucosidesImmunity, HumoralLipid AMice, Inbred C57BLPapioRecombinant ProteinsRNA, MessengerSchistosoma mansoniSchistosomiasis mansoniAdjuvants, ImmunologicAlum Compoundsaluminum sulfateAntigens, HelminthCytokinesglucopyranosyl lipid-AGlucosidesLipid ARecombinant ProteinsRNA, MessengerToll-Like Receptor 4Vaccinesbiomedical researchdisease models, animalenzyme-linked immunosorbent assayimmunizationinnate immune response

Identifiers

PMID29997146
PMCPMC6288690
OpenAlexW2823092210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.